SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Divisha Raheja, Charles Specht, Zachary Simmons, Paraproteinemic neuropathies, Muscle & Nerve, 2015, 51, 1
  2. 2
    C P Venner, J D Gillmore, S Sachchithanantham, S Mahmood, T Lane, D Foard, L Rannigan, S D J Gibbs, J H Pinney, C J Whelan, H J Lachmann, P N Hawkins, A D Wechalekar, A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis, Leukemia, 2014, 28, 12, 2304

    CrossRef

  3. 3
    Sajitha Sachchithanantham, Ashutosh D Wechalekar, Philip N Hawkins, An evaluation of current treatment options for immunoglobulin light-chain amyloidosis, Expert Opinion on Orphan Drugs, 2014, 2, 3, 229

    CrossRef

  4. 4
    Giampaolo Merlini, Raymond L Comenzo, David C Seldin, Ashutosh Wechalekar, Morie A Gertz, Immunoglobulin light chain amyloidosis, Expert Review of Hematology, 2014, 7, 1, 143

    CrossRef

  5. You have free access to this content5
    Morie A. Gertz, Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment, American Journal of Hematology, 2014, 89, 12
  6. 6
    Emma C. Scott, Stephen B. Heitner, William Dibb, Gabrielle Meyers, Stephen D. Smith, Farnoush Abar, Tibor Kovacsovics, Galit Perez-Avraham, Alex Stentz, Rachel Frires, James Dibb, Richard T. Maziarz, Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study, Clinical Lymphoma Myeloma and Leukemia, 2014, 14, 5, 424

    CrossRef

  7. 7
    Rahma Warsame, Soo Mee Bang, Shaji K. Kumar, Morie A. Gertz, Martha Q. Lacy, Francis Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Robert A. Kyle, Nelson Leung, John A. Lust, Stephen J. Russell, Thomas E. Witzig, Steven R. Zeldenrust, S. Vincent Rajkumar, Angela Dispenzieri, Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant, European Journal of Haematology, 2014, 92, 6
  8. 8
    Steven M. Devine, Re-Examining the Role of High-Dose Chemotherapy in the Treatment of Light Chain Amyloidosis, Biology of Blood and Marrow Transplantation, 2014, 20, 1, 14

    CrossRef

  9. 9
    Steven M. Devine, Reprint of: Re-Examining the Role of High-Dose Chemotherapy in the Treatment of Light Chain Amyloidosis, Biology of Blood and Marrow Transplantation, 2014, 20, 2, S2

    CrossRef

  10. 10
    J.-P. Fermand, F. Bridoux, R. A. Kyle, E. Kastritis, B. M. Weiss, M. A. Cook, M. T. Drayson, A. Dispenzieri, N. Leung, How I treat monoclonal gammopathy of renal significance (MGRS), Blood, 2013, 122, 22, 3583

    CrossRef

  11. You have free access to this content11
    Morie A. Gertz, Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment, American Journal of Hematology, 2013, 88, 5